⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Paul NorwoodM.D., F.A.C.P.

Endocrinology · Fresno, CA 93720

NPI: 1871503649

Share:

47

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peersElevated cost per beneficiaryHigh long-acting opioid rate vs peersElevated antipsychotic prescribing (65+)

Risk indicators are statistical patterns, not allegations. Learn more

11,439

Total Claims

$4.5M

Drug Cost

869

Beneficiaries

$5,189

Cost/Patient

Risk Score Breakdown 47/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Elderly antipsychotic prescribing+5
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 6,382 Endocrinology providers

+32%

Cost per patient vs peers

$5,189 vs $3,933 avg

-38%

Brand preference vs peers

31.9% vs 51.2% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

4.2%

Opioid Rate

478

Opioid Claims

$12K

Opioid Cost

18.0%

Long-Acting Rate

Brand vs Generic

68% generic

Brand: 3,510 claims · $4.2M

Generic: 7,498 claims · $286K

Patient Profile

71

Avg Age

55%

Female

1.42

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About